Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Repligen Corp
RGEN
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$184.69
8.89
5.06%
Ult. Agg.: Oct 28, 7:42 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
PRO
Perché si muove?:
Repligen shares are trading lower despite reporting better-than-expected Q3...
Utili:
I risultati di Q3 2026 sono stati pubblicati in data mar ott 27th, prima dell'apertura del mercato
Conference call:
La conference call più recente è iniziata alle 8:00 AM, 1 giorno fa
Clicca per vedere il webcast
Repligen Financials
Repligen (RGEN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Repligen Q3 Adj. EPS $0.53 Beats $0.46 Estimate, Sales $209.314M Beat $206.619M Estimate
Benzinga Newsdesk
PRO
Repligen Raises FY2026 Adj EPS Guidance from $2.03-$2.09 to $2.05-$2.09 vs $2.06 Est; Raises FY2026 Sales Guidance from $813.000M-$835.000M to $844.000M-$852.000M vs $829.693M Est
Repligen (NASDAQ:RGEN) raises FY2026 Adj EPS guidance from $2.03-$2.09 to $2.05-$2.09 vs $2.06 analyst estimate. Raises FY2026 sales outlook from $813.000 million-$835.000 million to $844.000 million-$852.000 million vs
Benzinga Newsdesk
PRO
Repligen Q2 Adj. EPS $0.54 Beats $0.45 Estimate, Sales $204.128M Beat $201.483M Estimate
Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.45 by 20 percent. This is a 45.95 percent increase over earnings of $0.37 per share from the same
Benzinga Newsdesk
PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.97-$2.05 to $2.03-$2.09 vs $2.00 Est; Raises FY2026 Sales Guidance from $803.000M-$833.000M to $813.000M-$835.000M vs $822.537M Est
Repligen (NASDAQ:RGEN) raises FY2026 Adj EPS guidance from $1.97-$2.05 to $2.03-$2.09 vs $2.00 analyst estimate. Raises FY2026 sales outlook from $803.000 million-$833.000 million to $813.000 million-$835.000 million vs
Benzinga Newsdesk
PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.93-$2.01 to $1.97-$2.05 vs $1.97 Est; Lowers FY2026 Sales Guidance from $810.000M-$840.000M to $803.000M-$833.000M vs $827.641M Est
CURRENT GUIDANCE (at May 5, 2026) FY 2026Adjusted (non-GAAP)Total Reported Revenue$803M - $833MReported Growth9% - 13%Organic Growth9% - 13%Gross Margin53.7% - 54.2%Income from Operations$124M - $132MOperating
Benzinga Newsdesk
PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.93-$2.01 to $1.97-$2.05 vs $1.97 Est
FINANCIAL GUIDANCE FOR FULL YEAR 2026All adjusted figures are non-GAAPOur financial guidance for the full year 2026 is based on expectations for our existing business. Our Adjusted (non-GAAP) guidance excludes the
Benzinga Newsdesk
